The current earnings forecast score of Zimmer Biomet Holdings Inc is 6.58, ranking 167 out of 199 in the Healthcare Equipment & Supplies industry. The average price target is 100.00, with a high of 125.00 and a low of 88.00.
Analyst Rating
Based on
29
analysts
Hold
Current Rating
99.720
Target Price
+2.64%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Zimmer Biomet Holdings Inc
ZBH
29
Medtronic PLC
MDT
33
Dexcom Inc
DXCM
31
Stryker Corp
SYK
30
Abbott Laboratories
ABT
29
Medline Ord Shs Class A
MDLN
29
1
2
3
...
22
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Zimmer Biomet Holdings Inc's expected revenue for the next quarter?
Zimmer Biomet Holdings Inc's expected revenue is 2.13B.
What is Zimmer Biomet Holdings Inc's price target?
Analysts forecast that Zimmer Biomet Holdings Inc's price target is USD 100.00, with the highest forecast at USD 125.00 and the lowest forecast at USD 88.00.
How have Zimmer Biomet Holdings IncZBH's recent earnings per share performed?
The market expectation was USD 1.22, while Zimmer Biomet Holdings IncZBH's earnings per share (EPS) for the previous quarter was USD 0.71. EPS for the next quarter is expected at USD 2.01.
What is the analyst rating for Zimmer Biomet Holdings Inc?
Based on the ratings of Zimmer Biomet Holdings Inc's stock from 29 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.